The trademark ANKYRON was filed by Proimmune Limited, a corporation established under the laws of the United Kingdom of Great Britain and Northern Ireland (the "Applicant"). The application was published for oppositions on September 2, 2021, and received undefined oppositions.
There are undefined Oppositions claimed against trademark.
The first opposition filed on November 28, 2021 by HELIOS HEALTHCARE SPAIN, S. L. U. on (a) Likelihood of confusion, (b) Unfair advantage and detriment to distinctiveness or repute. the opponent was represented by González Gómez, María Virtudes and its proceedings were handled in English The second opposition filed on October 18, 2021 by SANOFI on Likelihood of confusion. the opponent was represented by CASALONGA ALICANTE, S.L. and its proceedings were handled in English
The application was filed in English, and English was also language of all opposition proceedings (German was selected as the second language).
Appointment and Replacement of representative of the trademark registration was recorded on August 30, 2021.
The Opposition with reference B 003156904 was partially refused EUTMA/IR according to Article 8(1)(b) EUTMR with decision issued on November 2, 2023 by the EUIPO. The Opposition with reference B 003159171 was rejected according to Article 8(1)(b) EUTMR with decision issued on April 28, 2024 by the EUIPO. The Appeal with reference B R1218/2024-2 was Trade mark application allowed according to Article 8(1)(b) EUTMR with decision issued on December 9, 2024 by the EUIPO.